1. Home
  2. XBIO vs MLEC Comparison

XBIO vs MLEC Comparison

Compare XBIO & MLEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xenetic Biosciences Inc.

XBIO

Xenetic Biosciences Inc.

HOLD

Current Price

$2.13

Market Cap

4.8M

Sector

Health Care

ML Signal

HOLD

Logo Moolec Science SA

MLEC

Moolec Science SA

HOLD

Current Price

$5.53

Market Cap

4.7M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
XBIO
MLEC
Founded
N/A
2008
Country
United States
Cayman Islands
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Blank Checks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
4.8M
4.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
XBIO
MLEC
Price
$2.13
$5.53
Analyst Decision
Hold
Analyst Count
1
0
Target Price
N/A
N/A
AVG Volume (30 Days)
27.3K
894.7K
Earning Date
03-17-2026
02-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,858,935.00
N/A
Revenue This Year
$1.99
$20.42
Revenue Next Year
$20.00
$30.00
P/E Ratio
N/A
N/A
Revenue Growth
13.30
170.36
52 Week Low
$1.90
$3.08
52 Week High
$13.93
$120.00

Technical Indicators

Market Signals
Indicator
XBIO
MLEC
Relative Strength Index (RSI) 40.19 54.43
Support Level $2.05 $4.79
Resistance Level $2.69 $5.89
Average True Range (ATR) 0.13 1.04
MACD -0.04 -0.30
Stochastic Oscillator 6.76 22.74

Price Performance

Historical Comparison
XBIO
MLEC

About XBIO Xenetic Biosciences Inc.

Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors.

About MLEC Moolec Science SA

Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline, such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's maximum revenues from operations in Argentina.

Share on Social Networks: